Archive for November 2019

It’s time for Massachusetts to regain its historic status as a public education leader. Updating our state school-funding formula is an excellent start. But rather than mar this progress by doubling down on our failed test-and-punish approach, we should enable districts to use the funds to chart a new course toward educational equity and excellence…

Fentanyl is increasingly the driver of overdose deaths in the Bay State, according to figures released this week by the Department of Public Health. Read More

Two of Greater Boston’s longtime biotech rivals, Dicerna Pharmaceuticals Inc. and Alnylam Pharmaceuticals, may have resolved their legal fights, but a battle for market dominance looms in 2020. Read More

Margaret Low will take over the top role at the nonprofit public media organization owned by Boston University. Read More

The company pointed to Dybeck Happe’s focus on cutting down AP Moller-Maersk’s debt and altering its business portfolio to increase profitability, two of the primary tasks facing GE CEO Larry Culp. Read More

Good morning, everyone. Here are the 5 Things You Need to Know to get your Monday started on this short workweek. Read More

The $50 million first-of-its-kind center will explore regenerative therapies in a cross-sector environment. Read More

In July, Gov. Charlie Baker signed off on a proposal allowing the state’s MassHealth program to negotiate the prices of drugs with manufacturers. Four months later, the program is already saving the state millions of dollars. Read More

Cerner continues its restructuring plan, which includes layoffs — about 285 since September — as well as hiring — more than 4,000 this year. This round of job cuts will be the last this year, a spokeswoman says. Read More